Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hematologic”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT04794296
What this trial is testing

Recommendations for the Treatment of Children With Acute Lymphoblastic Leukemia in the GFAOP

Who this might be right for
Childhood ALL
French Africa Pediatric Oncology Group 500
Early research (Phase 1)Study completedNCT00002946
What this trial is testing

Penclomedine in Treating Patients With Solid Tumors or Lymphoma

Who this might be right for
LymphomaUnspecified Adult Solid Tumor, Protocol Specific
National Cancer Institute (NCI) 30
Early research (Phase 1)WithdrawnNCT05720988
What this trial is testing

Tagraxofusp to Eradicate Measurable Residual Disease in Patients With Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid Leukemia
Jonsson Comprehensive Cancer Center
Early research (Phase 1)Ended earlyNCT04318327
What this trial is testing

BCMA-directed CAR-T Cell Therapy in Adult Patients With Multiple Myeloma

Who this might be right for
Multiple Myeloma
Novartis Pharmaceuticals 96
Post-approval studies (Phase 4)UnknownNCT00192673
What this trial is testing

Poly(Ethylene Glycol)(PEG)-Asparaginase During Two Treatment Courses

Who this might be right for
Acute Lymphoblastic Leukemia
Nordic Society for Pediatric Hematology and Oncology 85
Testing effectiveness (Phase 2)Ended earlyNCT00281931
What this trial is testing

Fludarabine, Cyclophosphamide, and Rituximab in Treating Patients With Prolymphocytic Leukemia

Who this might be right for
Prolymphocytic Leukemia
German CLL Study Group 21
Early research (Phase 1)Not Yet RecruitingNCT07692529
What this trial is testing

A Clinical Study on the Efficacy and Safety of Zeprumetostat in Relapsed/Refractory Large Granular Lymphocyte Leukemia

Who this might be right for
Large Granular Lymphocyte LeukemiaT-LGL Leukemia
Institute of Hematology & Blood Diseases Hospital, China 10
Large-scale testing (Phase 3)Study completedNCT00008229
What this trial is testing

Melphalan With or Without Holmium Ho 166 DOTMP Followed by Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma

Who this might be right for
Multiple Myeloma and Plasma Cell Neoplasm
Fred Hutchinson Cancer Center
Testing effectiveness (Phase 2)Study completedNCT03701295
What this trial is testing

Pinometostat and Azacitidine in Treating Patients With Relapsed, Refractory, or Newly Diagnosed Acute Myeloid Leukemia With 11q23 Rearrangement

Who this might be right for
Acute Myeloid Leukemia With t(9;11)(p21.3;q23.3); MLLT3-MLLLeukemia CutisRecurrent Acute Myeloid Leukemia+1 more
National Cancer Institute (NCI) 1
Not applicableStudy completedNCT06886477
What this trial is testing

Sickle Cell, Pain and Mediterranean Diet

Who this might be right for
Sickle CellSickle Cell DiseaseSickle Cell Disease Without Crisis+1 more
University of Illinois at Chicago 37
Not applicableActive Not RecruitingNCT07156357
What this trial is testing

Surface EMG Testing on Swallowing in EoE Patients

Who this might be right for
Eosinophilic Esophagitis (EoE)
Mayo Clinic 30
Not applicableStudy completedNCT01900119
What this trial is testing

A Description of Bacteria in the Mouths of Patients With Severe Aplastic Anemia

Who this might be right for
Severe Aplastic Anemia (SAA)
National Institutes of Health Clinical Center (CC) 24
Large-scale testing (Phase 3)Active Not RecruitingNCT05653219
What this trial is testing

Efficacy and Safety of Ianalumab Versus Placebo in Addition to Eltrombopag in Primary Immune Thrombocytopenia Patients Who Failed Steroids

Who this might be right for
Primary Immune Thrombocytopenia
Novartis Pharmaceuticals 152
Testing effectiveness (Phase 2)Looking for participantsNCT07512700
What this trial is testing

Venetoclax Combined With CACAG Regimen Versus "3+7" Regimen in the Treatment of Acute Monocytic Leukemia

Who this might be right for
Acute Monocytic Leukemia
Chinese PLA General Hospital 204
Testing effectiveness (Phase 2)WithdrawnNCT03168100
What this trial is testing

2017-03: A Single-Arm, Open-label Study of Anti-Signaling Lymphocytic Activation Molecule F7 (Anti-SLAMF7) Monoclonal Antibody (mAb) Therapy After Autologous Stem Cell Transplant in Patients With Multiple Myeloma

Who this might be right for
Multiple Myeloma
University of Arkansas
Early research (Phase 1)Study completedNCT02142400
What this trial is testing

Multiple Ascending Dose Study of DS-1093 in Healthy Subjects

Who this might be right for
Anaemia
Daiichi Sankyo 31
Not applicableUnknownNCT04778072
What this trial is testing

A Clinical Study on Adherence and Efficacy of Different Doses of Active Iron in Treatment Resistant Subjects

Who this might be right for
PremenopauseIron-deficiencyIron Adverse Reaction+2 more
Solvotrin Innovations Ltd 60
Post-approval studies (Phase 4)Study completedNCT06425757
What this trial is testing

Study on Pharmacokinetics of Single Injection of Ciprofol in Patients With Moderate to Severe Hypoproteinemia

Who this might be right for
HypoproteinemiaPharmacokineticsCiprofol
Xie Kangjie 36
Not applicableLooking for participantsNCT06691867
What this trial is testing

Integrative Training Program for Pediatric Sickle Cell Pain

Who this might be right for
Sickle Cell Disease
Emory University 155
Testing effectiveness (Phase 2)Ended earlyNCT00509600
What this trial is testing

Etanercept (Enbrel) for Juvenile Myelomonocytic Leukemia

Who this might be right for
Leukemia
M.D. Anderson Cancer Center 1
Next Page